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plays a critical role in human muscle diseases in vivo; and they
represent an important proof of principle that hereditary muscle
diseases can be cured with proper drugs downstream of the genetic
lesion if the pathogenetic mechanisms are understood. This is a useful
example of how translational medicine can rapidly move from animal
models to treatment of human diseases; and of how mitochondrial
medicine may be useful beyond the cure of primary mitochondrial
diseases.
doi:10.1016/j.bbabio.2008.05.035
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Distance is the principal parameter that sets the order of
magnitude for electron-tunneling rates; however, there continue
to be varying ways to measure electron-tunneling distances in
proteins. This distance uncertainty blurs the issue of whether the
intervening protein medium has been naturally selected to speed or
slow any particular electron-tunneling reaction. For redox cofactors
lacking metals, or for chlorophylls, distances can be deﬁned from
conjugated cofactor edge atoms, approximating the space that
includes most of the tunneling electron wavefunction. However, for
the iron-containing heme, an appropriate cofactor edge is ambig-
uous. Electron-tunneling distances may be measured from the
conjugated heme macrocycle edge or from the metal, which can be
up to a signiﬁcant 4.8 Å longer. To address this ambiguity, we
consider both natural heme protein electron transfer and light-
activated electron transfer in ruthenated heme proteins. We ﬁnd
that the edge of the conjugated heme macrocycle provides a reliable
and useful tunneling distance deﬁnition consistent with other
biological electron-tunneling reactions. Furthermore, with this
distance metric, heme axially- and edge-oriented electron transfers
appear similar and are equally well described by a simple square
barrier tunneling model. This is in contrast to recent reports for
metal-to-metal metrics that require exceptionally poor donor/
acceptor couplings to explain heme axially-oriented electron
transfers.
doi:10.1016/j.bbabio.2008.05.036
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Recent progress in understanding the Q-cycle mechanism of the
bc1 complex is reviewed. The data strongly support a mechanism in
which the Qo-site operates through a reaction in which the ﬁrst
electron transfer from ubiquinol to the oxidized iron–sulfur protein
is the rate determining step for the overall process. The reaction
involves a proton-coupled electron transfer down a hydrogen bond
between the ubiquinol and a histidine ligand of the [sFe-2S] cluster,
in which the unfavorable protonic conﬁguration contributes a
substantial part of the activation barrier. The reaction is endergonic,
and the products are an unstable ubisemiquinone bound at the Qo-
site, and the reduced iron–sulfur protein, the extrinsic mobile
domain of which is now moves away to deliver an electron to cyt c1
and liberate the H+. When oxidation of the semiquinone is
prevented, it participates in bypass reactions, including superoxide
generation if O2 is available, which are minimized by the above
characteristics, and through coulombic gating. The mechanism
discussed is monomeric, but the literature suggests that the dimeric
structure participates in a more complicated mechanism. We show
from myxothiazol titrations and mutational analysis of cyt b Tyr-
199, that no inter-monomer electron transfer occurs at the level of
the bL hemes. Analysis of strains with mutations at Asn-221 shows
that there are coulombic interactions between the b-hemes in a
monomer, and likely also across the dimer interface.
doi:10.1016/j.bbabio.2008.05.037
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The mitochondrion is a self contained biochemical machine
involved numerous functions of the cell. A quantitative mathema-
tical model of mitochondria function reveals deﬁcits in our
understanding of this process including the enzyme catalyzed
reaction pathways and kinetics, post-translational modiﬁcations
and chemical activity of reaction intermediates. To begin to ﬁll
these gaps, the tissue speciﬁc mitochondrial biochemical pathways
have been characterized using quantitative proteomics by several
groups. Using this data, the nuclear “protein program” for a
mitochondrial function was evaluated. An example of “reprogram-
ming” associated with Type I diabetes will be discussed. With this
metabolic roadmap, the acute regulation of enzymatic function was
evaluated by screening matrix phosphoproteome using ﬂuorescent
probes, isoelectric focusing and 32P labeling. These studies reveal an
extensive and dynamic matrix phosphoproteome. The functional
signiﬁcance, speciﬁc interaction sites and nature of the matrix
kinase/phosphatase system, including autophosphorylation, are
being investigated. All of these approaches, along with those
from many other laboratories, begin to ﬁll in the gaps in a
quantitative consensus model of mitochondrial function. Clearly
this type of systematic approach will need to be continued to
establish the entire mitochondria metabolic reaction network and
its regulation.
doi:10.1016/j.bbabio.2008.05.038
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ATP synthases operating in tandem with a respiration or light-
driven proton pump use protons and those operating in tandemwith a
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